OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/26/2025
Back to search
Official data from USPTO
HANALL BIOPHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
25
Latest update
04/03/2026
Trademark type
Combined
Nice classes
5, 35, 42
Filing date
11/16/2023
Registration date
12/24/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/24/2024
Last transaction
04/03/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
03
Owner location
KR
Examiner
JOHNSON, AISHA CLARKE
Law office
L10
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of the stylized wording HANALL BIOPHARMA in black, above the wording are three abstract designs of chromosomes in the colors green, yellow, and blue.
Holders and representatives
Holders
Hanall Biopharma Co., Ltd.
Representatives
John M. Kim IPLA, LLP
Technical classification
Nice Classes
Class 5Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for use in diagnostic testing of Hepatitis B surface antibody for medical purposes and pharmaceutical agents affecting sensory organs; thyroid and para-thyroid hormone preparations; tonicsmedicines for autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; anthelmintics; antiemetics; local anaesthetics; anti-cough drops; pituitary hormone preparations; pharmaceutical preparations for treating diabetes; pharmaceutical agents affecting metabolism; veterinary preparations for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; prescription synthetic narcotics; anaesthetics; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for immunity improvement; pharmaceutical agents for treating physically caused lesions; pharmaceuticals for the treatment of erectile dysfunction; vesicants for wart removal; vaccines; adrenal hormone preparations; pharmaceutical preparations for the treatment of urogenital organs; vitamin preparations; pharmaceutical products for the treatment of bone diseases; crude medicines for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; biological preparations for veterinary purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; chemical preparations for veterinary purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; cardiovascular pharmaceutical preparations; chemico-pharmaceutical preparations for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; pharmaceutical agents for epidermis; medicines for the treatment of gastrointestinal diseases; diagnostic preparations for medical or veterinary purposes; drugs for medical purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; medical diagnostic reagents; diuretics; medicines for human purposes for the treatment of autoimmune diseaseocular diseaseear diseaseneurodegenerative diseasecancer; antacids; haematogen; pharmaceutical preparations for the treatment of tumours; pharmaceutical preparations acting on the central nervous system; analgesics; medical preparations for slimming purposes; medicines for dental purposes; dermatological pharmaceutical products; antibiotics; anti-cancer preparations; blood solvents for medical or veterinary purposes; pharmaceutical preparations for the treatment of respiratory organs; preparations for the treatment of burns; chemotherapeutics
Class 35
Price comparison services; distribution of samples; wholesale store services featuring nutraceuticals for use as a dietary supplement; retail store services featuring nutraceuticals for use as a dietary supplement; wholesale store services featuring medical apparatus; retail store services featuring medical apparatus; wholesale store services featuring medical apparatus and instruments; retail store services featuring medical apparatus and instruments; wholesale store services featuring pharmaceuticals; retail store services featuring pharmaceuticals; wholesale store services featuring medicines for human purposes; retail store services featuring medicines for human purposes; wholesale store services featuring fruit-based dietary supplements via the internet; retail store services featuring fruit-based dietary supplements via the internet; wholesale store services featuring make-up preparations via the internet; retail store services featuring make-up preparations via the internet; wholesale store services featuring nutraceuticals via the internet; retail store services featuring nutraceuticals via the internet; wholesale store services featuring make-up preparations; retail store services featuring make-up preparations
Class 42
Advice in the field of construction drafting; engineering surveying; rental of scientific equipment; research relating to mechanical engineering; meteorological observation for others; services for assessing the safety of agricultural chemicals; cosmetology research services; industrial design; pharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research services; scientific research services in the fields of medicinehealth and pharmacology; medical research; product safety testing; textile design; research in the field of computer software development; marineaerial and land surveying; oceanography research; chemical analysis; scientific research in the nature of providing environmental impact surveys
Publications
History of USPTO decisions and trademark events.
25 publications found
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
07/07/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
07/07/2025
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/05/2025
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/15/2025
FIMP
FINAL DISPOSITION PROCESSED
06/14/2025
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/25/2025
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/24/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/24/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/22/2024
PUBO
PUBLISHED FOR OPPOSITION
10/22/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/12/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/06/2024
RFNT
REFUSAL PROCESSED BY IB
08/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/16/2024
RFRR
REFUSAL PROCESSED BY MPU
07/16/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
06/25/2024
CNRT
NON-FINAL ACTION WRITTEN
06/24/2024
DOCK
ASSIGNED TO EXAMINER
06/21/2024
MAFR
APPLICATION FILING RECEIPT MAILED
02/16/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/12/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/09/2024
Continuous trademark protection
Get notified about every new filing that threatens HANALL BIOPHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.